Associations Between Chemotherapy-Induced Nausea in Patients With Genitourinary, Sarcoma or Melanoma Cancers and Changes in Gut Microbiome: Potential for Precision Therapeutics

TerminatedOBSERVATIONAL
Enrollment

13

Participants

Timeline

Start Date

April 19, 2023

Primary Completion Date

May 21, 2024

Study Completion Date

May 21, 2024

Conditions
Bladder CancerProstate CancerTesticular CancerBladder CarcinomaGenitourinary System CarcinomaMalignant Testicular NeoplasmMelanomaProstate CarcinomaSarcoma
Interventions
OTHER

Blood and Tissue

"Patients will collect stool for microbiome analysis at baseline (i.e., 3 +2 days prior to chemotherapy) and again 5-7 days following initiation of chemotherapy.~Blood samples will be collected prior to their first chemotherapy treatment, and in the second week after chemotherapy."

Trial Locations (3)

55905

Mayo Clinic, Rochester

85259

Mayo Clinic, Scottsdale

32224-9980

Mayo Clinic, Jacksonville

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Mayo Clinic

OTHER

NCT05819827 - Associations Between Chemotherapy-Induced Nausea in Patients With Genitourinary, Sarcoma or Melanoma Cancers and Changes in Gut Microbiome: Potential for Precision Therapeutics | Biotech Hunter | Biotech Hunter